Abstract
Neurocritical care patients may benefit from personalized treatment based on their cerebral autoregulatory function. The pressure reactivity index is an important, prevalent metric used to estimate the state of a patient’s cerebral autoregulation and guide clinical decision-making. However, the pressure reactivity index is highly sensitive to hyperparameter choices and intrapatient variability. In this manuscript, we develop a new personalized pressure reactivity index methodology (pPRx) that increases robustness and reduces the noise of the pressure reactivity index calculation. Using data from traumatic brain injury patients and simulated data, we first show that pressure reactivity index sensitivity to hyperparameters and interpatient variability is large enough to influence clinical interpretation of cerebral autoregulatory function. We identify that patient heart rate is closely related to errors in the pressure reactivity index, which has vital implications for extending the use of PRx to patients with different regular heart rates, such as pediatric populations. We then remove this heart rate-specific sensitivity in the pPRx methodology by adjusting for patient heart rate at resolutions of single heartbeats. Implementing the pPRx methodology decreases error, noise, and sensitivity, and allows the pressure reactivity index to be more robust to variability across patient populations. We also leverage our data and analysis to identify ideal averaging windows in the standard method.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by National Institutes of Health R01s LM006910 and LM012734 to DJA, and National Science Foundation (NSF) Graduate Research Fellowship DGE-1938058 Briggs to JKB
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee/IRB of the respective institutions enrolled in TRACK-TBI gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Included additional validation data set.
Data Availability
All simulated data and code will be made available at: https://github.com/jenniferkbriggs/PRxAnalysis.git Patient data can be requested by contacting TRACK-TBI.
https://github.com/jenniferkbriggs/PRxAnalysis.git
https://tracktbi.ucsf.edu/transforming-research-and-clinical-knowledge-tbi
